Publications by authors named "Koen Iterbeke"

Claim this Profile
D
Darunavir/cobicistat once daily for the treatment of HIV.
Thomas N Kakuda, Herta Crauwels, Magda Opsomer, Frank Tomaka, Tom van de Casteele, Koen Iterbeke

Expert Rev Anti Infect Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers.
Thomas N Kakuda, Magda Opsomer, Maarten Timmers, Koen Iterbeke, Tom Van De Casteele

J Clin Pharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.
Lieven Baert, Gerben van 't Klooster, Willy Dries, Marc François, Alfons Wouters, Koen Iterbeke

Eur J Pharm Biopharm· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
Elisa García-Garayoa, Peter Bläuenstein, Matthias Bruehlmeier, Alain Blanc, Koen Iterbeke

J Nucl Med· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
Ralf Bergmann, Matthias Scheunemann, Christoph Heichert, Peter Mäding, Holm Wittrisch, Koen Iterbeke

Nucl Med Biol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis